Skip to main content

Table 2 Association between age, hormone receptor positivity and therapy response

From: Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

Therapy response category N HR status (%) p1 Average age at diagnosis (year ± SD) p2
HR+ HR− HR+ HR− all
pCR 23 5 (21.7) 18 (78.3) <0.001 44.2 ± 12.6 46.4 ± 13.8 46.0 ± 13.3 0.008
pPR 73 55 (75.3) 18 (24.7) 50.0 ± 11.0 52.3 ± 12.8 50.4 ± 11.4
pNR 24 20 (83.3) 4 (16.7) 55.9 ± 10.7 53.3 ± 14.5 55.6 ± 11.0
  1. HR – hormone receptor positive (+) or negative (−)
  2. 1two-sided Fisher’s exact test; 2Kruskal-Wallis H-test with Dunn’s posthoc (multiple comparison) test for all samples without regarding the HR status